Except as provided in Rule
64E-5.657, F.A.C., the licensee
shall require an authorized user for the oral administration of sodium iodide
I-131 requiring a written directive in quantities greater than 1.22
Gigabecquerels (33 millicuries), to:
(2) Be an authorized user under
Rule
64E-5.660, F.A.C., for uses
listed in sub-sub-subparagraph
64E-5.660(2)(a)
2.g.(II), F.A.C., NRC or equivalent Agreement State requirements; or
(3)
(a)
Have successfully completed 80 hours of classroom and laboratory training,
applicable to the medical use of sodium iodide I-131 for procedures requiring a
written directive. The training must include:
1. Radiation physics and
instrumentation;
2. Radiation
protection;
3. Mathematics
pertaining to the use and measurement of radioactivity;
4. Chemistry of radioactive material for
medical use; and
5. Radiation
biology; and
(b) Have
work experience, under the supervision of an authorized user who meets the
requirements in Rules
64E-5.657,
64E-5.660 or
64E-5.662, F.A.C., NRC or
equivalent Agreement State requirements. A supervising authorized user, who
meets the requirements in subsection
64E-5.660(2),
F.A.C., must also have experience in administering dosages as specified in
sub-sub-subparagraph
64E-5.660(2)(a)
2.g.(II), F.A.C. The work experience must involve the following:
1. Ordering, receiving, and unpacking
radioactive materials safely and performing the related radiation
surveys;
2. Performing quality
control procedures on instruments used to determine the activity of dosages and
performing checks for proper operation of survey meters;
3. Calculating, measuring, and safely
preparing patient or human research subject dosages;
4. Using administrative controls to prevent a
medical event involving the use of radioactive material;
5. Using procedures to contain spilled
radioactive material safely and using proper decontamination procedures;
and
6. Administering dosages to
patients or human research subjects, that includes at least 3 cases involving
the oral administration of greater than 1.22 gigabecquerels (33 millicuries) of
sodium iodide I-131; and
(c) Have obtained written attestation that
the individual has satisfactorily completed the requirements in paragraphs
64E-5.662(3)(a)
and
64E-5.662(3)(b),
F.A.C., of this section, and have demonstrated the ability to function
independently as an authorized user to fulfill the radiation safety related
duties for a medical use licensee authorized under Rule
64E-5.626,
64E-5.627 or
64E-5.630, F.A.C., that require
written directives. Have obtained written attestation, signed by a preceptor
authorized user or a residency program director who represents a consensus of
residency program faculties (as long as at least one member of the residency
program faculty is an authorized individual in the same category designated by
the applicant seeking authorized status) who meets the requirements in Rule
64E-5.657,
64E-5.660 or
64E-5.662, F.A.C., NRC or
equivalent Agreement State requirements. A preceptor authorized user, who meets
the requirements in subsection
64E-5.660(2),
F.A.C., must also have experience in administering dosages as specified in
sub-sub-subparagraph
64E-5.660(2)(a)
2.g.(II), F.A.C.
Notes
Fla. Admin.
Code Ann. R. 64E-5.662
Rulemaking Authority 404.051, 404.061, 404.071, 404.081,
404.141 FS. Law Implemented
404.022,
404.051(1), (4), (5), (6), (8), (9), (10),
(11),
404.061(2),
(3),
404.071(1),
404.081,
404.141
FS.
New 2-11-10, Amended
12-26-13.
New 2-11-10, Amended
12-26-13.